BTG2018 AGENDA

The registration fee to attend this conference includes three days of scientific sessions, workshops, lunch sessions, coffee breaks and corporate mini symposiums. All BTG2018 registered delegates will also have access to the Korean Society of Hematology Meeting.
DAY 1: MARCH 29, 2018

8:00 AM STEM CELL TRANSPLANT SYMPOSIUM 1 
Update on Haplo Transplant outcomes
(Moderator: Jong Wook Lee, Korea and Surapol Issaragrisil, Thailand)  
  1. Conditioning regimen in haploidentical HSCT: Hee Je Kim, Korea (20 min)  
  2. Post Transplant Cyclophophamide: Didier Blaise, France (20 min)
  3. Evolving criteria for donor selection for transplants in acute leukemia : Is HLA matched sibling donor always better than haploidentical donor?: Xiao Jun Huang, China (20 min)
  4. Haplo Transplant for genetic diseases: Suradej Hongeng, Thailand (20 min)
  5. Advances in conditioning regimen for Haplo Transplant: Borje Andersson, USA (20 min)

9:30 AM: COFFEE BREAK

10:00 AM STEM CELL TRANSPLANT SYMPOSIUM 2 
Update on Cord Transplant outcomes
(Moderator: Hoon Kook, Korea and Kaiyan Liu, China) 
  1. Clinical outcomes of adult cord blood transplantation: Byung Soo Kim, Korea (20 min)
  2. Clinical outcomes of pediatric cord blood transplantation: Jaap Boelens, Netherlands (20 min)
 
Prevention and treatment of GVHD
(Moderator: Hong Ki Lee, Korea and Didier Blaise, France)  
  1. Role of Anti-Thymocyte Globulin in prevention and treatment of GVHD: Kyoo-Hyung Lee, Korea (20 min)
  2. Regulatory T cells in prevention and treatment of GVHD: Simrit Parmar, USA (20 min)
 
Infectious complications
(Moderator: Jong-Ho Won, Korea and Surapol Issaragrisil, Thailand) 
  1. Post-BMT fungal infection: Dong Gun Lee, Korea (20 min)
  2. Cell therapy for viral infections: Simrit Parmar, USA (20 min)

12:00 PM: JOINT LUNCH SYMPOSIUM WITH ICKSH2018

2:00 PM BTG2018 INAUGURATION AND OPENING SPEECH
Surapol Issaragrisil, Thailand, Borje Andersson, USA, Xiao Jun Huang, China and Hyeoung-Joon Kim, Korea

2:30 PM ACUTE MYELOID LEUKEMIA
(Moderator: KSH: Hyeoung-Joon Kim, Korea and Kaiyan Liu, China)
  1. Ideal induction therapy for newly diagnosed AML: Do we have a consensus?: Steve Kornblau, USA (20 min)
  2. Advances in treatment for elderly AML: Didier Blaise, France (20 min)
  3. Risk stratification and treatment of therapy-related AML: Junshik Hong, Korea (20 min)
  4. AML postremission treatment: Takahiro Yamauchi. Japan (20 min)
  5. Decision analysis of post remission therapy for acute promyelocytic leukemia: Jiong Hu, China (20 min)

4:30 PM MYELOPROLIFERATIVE NEOPLASMS EXCEPT FOR CML
(Moderator: KSH: Chul-Won Choi, Korea and Borje Andersson, USA)
  1. Treatment decision based on mutation status-incorporated risk stratification of PV/ET/ MF: Steve Kornblau, USA (20 min)
  2. Allogeneic Stem Cell Transplant for Myelofibrosis: Hari Parmeswaran, USA (20 min)
  3. Current treatment of hydroxyurea-intolerant or resistant patients with PV/ET : Sung-Yong Kim, Korea (20 min) 

5:30 PM ADJOURN

6:00 PM OPENING RECEPTION DINNER
DAY 2: MARCH 30, 2018

8:00 AM APLASTIC ANEMIA
(Moderator: Jong Wook Lee, Korea and Surapol Issaragrisil, Thailand)
  1. Non Transplant Therapies for AA: Shreyans Gandhi, UK (20 min)
  2. Donor Selection and Conditioning Regimen: Suradej Hongeng, Thailand (20 min)
  3. Early risk assessment for leukemic transformation of AA: Hari Parmeswaran, USA (20 min)
  4. The risk factors and management of thrombosis in PNH: Jun Ho Jang, Korea (20 min)
  5. Future therapeutic strategies in PNH: Jun-ichi Nishimura, Japan (20min)
​
10:30 AM: COFFEE BREAK and POSTER VIEWING

11:00 AM IMMUNE THROMBOCYTOPENIA (ITP)
(Moderator: Doyeon Oh, Korea and Surapol Issaragrisil, Thailand) 
  1. Overviews of current practice guidelines for ITP: Raymond Wong, Hong Kong (20 min)
  2. Screening and treatment of Helicobactor Pylori in ITP: Hyo Jung Kim, Korea (20 min)
  3. TPO mimetics or splenectomy as second-line treatment: Jun Ho Jang, Korea (20 min)
​
12:00 PM LUNCH

1:00 PM MULTIPLE MYELOMA
 
MULTIPLE MYELOMA: NEWLY DIAGNOSED 
(Moderator: Robert Orlowski, USA and James Chim, Hong Kong)
  1. Risk stratification, response evaluation and monitoring of multiple myeloma: Wee Joo chng, Singapore (20 min)
  2. Frontline Therapy for Transplant Eligible Myeloma Patients: Jin Seok Kim, Korea (20 min)
  3. Treatment of Elderly Newly Diagnosed Multiple Myeloma Patients: Jin Lu (20 min)
 
MULTIPLE MYELOMA: RELAPSED 
(Moderator: Jae Hoon Lee, Korea and Hari Parmeswaran, USA)
  1. The impact of proteasome inhibitor & antibody on high-risk cytogenetics in MM: an appraisal of RCT: James Chim, Hong Kong (20 min)
  2. Changing Landscape of Myeloma Therapy: Focus on Immunotherapy: Je Jung Lee, Korea (20 min)
  3. Changing Landscape of Myeloma Therapy: Focus on high risk relapse (extramedullary disease, etc): Shang-Yi Huang, Taiwan (20 min)
  4. Management of Bone Disease in Myeloma: Robert Orlowski, USA (20 min)

3:30 PM COFFEE BREAK and POSTER VIEWING

4:00 PM ACUTE LYMPHOBLASTIC LEUKEMIA
(Moderator: Hyoung Jin Kang (Pediatric ALL)/ Adolfo de la Fuente, Spain (Adult ALL) 
  1. Newly emerging immunotherapeutic agents in ALL: Jaap Boelens, Netherlands (20 min)
  2. CAR - T Cell Adoptive Therapy for B-ALL: Hari Parmeswaran, USA (20 min)
  3. ALL in adolescents & young adults: Daisuke Tomizawa, Japan (20 min)
  4. Targeted Therapies in adult Ph+ALL: Dr. Ho Young Yhim, Korea (20min)

5:30 PM ADJOURN

6:00 PM GALA DINNER
DAY 3: MARCH 31, 2018

8:00 AM CHRONIC MYELOID LEUKEMIA
(Moderator: Chulwon Jung, Korea and Didier Blaise, France)
  1. Consensus guidelines for diagnosis and response: Elias Jabbour, USA (20 min)
  2. Patient-reported outcome in CML: Qian Jiang, China (20 min)
  3. Frontline Therapy for Newly Diagnosed CML: Won Sik Lee, Korea (20 min)
  4. Genetic changes in CML progression: Hongtae Kim, Korea (20 min)
  5. Subline Therapy for relapsed and refractory CML: Shreyans Gandhi, UK (20 min)
  6. Treatment Free Remission: Sung Hyun Kim, Korea (20 min)
​
10:00 AM COFFEE BREAK and POSTER VIEWING

10:30 AM KIAN ANG MEMORIAL LECTURE 
(Moderator: Borje Andersson, USA)
Topic: Is Measurable Residual Disease (MRD)-Testing the Greatest Discovery Since Fire?
Speaker: Robert Peter Gale, USA

11:00 AM BEST ORAL ABSTRACT PRESENTATION
Moderator: Steven Kornblau (USA) and Jaap Boelens (Netherlands)
Top 4 selected abstracts at 10 minutes each

12:00 PM MYELODYSPLASTIC SYNDROME
(Moderator: Je-Hwan Lee, Korea and Borje Andersson, USA) 
  1. Novel Diagnostic Criteria of Myelodysplastic Syndromes(MDS)-The 2016 Revision of WHO Classification: Pei LIn, USA (20 min)
  2. Today's treatment options for MDS: HMT & BMT: Seung Ah Yahng, Korea (20 min)
  3. Tomorrow's treatment options for MDS: novel agents: Shreyans Gandhi, UK (20 min)
​
1:00 PM LUNCH

2:00 PM CHRONIC LYMPHOCYTIC LEUKEMIA
(Moderator: Constantine Tam, Australia and Ashok Vaid, India)
  1. Novel Targeted Therapies for CLL: Constantine Tam, Australia (20 min)
  2. Newly Diagnosed Mantle Cell Lymphoma: Hong Jung Yong, Korea (20 min)
  3. Newly Diagnosed Follicular Lymphoma: Chemo- vs. Targeted Therapy?: Adolfo de la Fuente, Spain (20 min)
​
3:00 PM HODGKIN'S LYMPHOMA 
(Moderator: YL Kwong, Hong Kong and Hari Parmeswaran, USA)
  1. Current Management of Hodgkin's Lymphoma: Eom HS, Korea (20 min)
  2. Immunotherapy and Novel Agents in Hodgkin's Lymphoma: Frederick Hagemeister, USA (20 min)

3:40 PM COFFEE BREAK and POSTER VIEWING

3:50 PM NON HODGKIN'S LYMPHOMA
(Moderator: YL Kwong, Hong Kong and Daryl Tan, Singapore)
  1. Revised Classification, New Diagnostic Criteria for Non-Hodgkin's Lymphoma: Kengo Takeuchi, Japan (20 min)
  2. Immunotherapy for B-Cell Lymphoma (includes cell therapy): Frederick Hagemeister, USA (20 min)
 
4:30 PM DIFFUSE LARGE B CELL LYMPHOMA
(Moderator: Won Seog, Kim, Korea and Surapol Issaragrisil, Thailand)
  1. Diagnosis and Treatment: Newly diagnosed DLBCL: Daryl Tan, Singapore (15 min)
  2. Approach to Primary Treatment Failure DLBCL: Kwong YL, Hong Kong (15 min)
  3. Post Auto-Stem Cell Transplant Relapse: Ashok Vaid, India (15 min)
  4. Management of CNS involvement in DLBCL: Kim SJ, Korea (15 min) 

​5:30 PM ADJOURN